D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Snap
SNAP
|
+$436M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$373M |
| 3 |
Fidelity National Information Services
FIS
|
+$351M |
| 4 |
Cisco
CSCO
|
+$350M |
| 5 |
Lockheed Martin
LMT
|
+$348M |
Top Sells
| 1 |
Tesla
TSLA
|
+$771M |
| 2 |
Advanced Micro Devices
AMD
|
+$593M |
| 3 |
Boeing
BA
|
+$590M |
| 4 |
Lowe's Companies
LOW
|
+$519M |
| 5 |
Alibaba
BABA
|
+$352M |
Sector Composition
| 1 | Technology | 19.42% |
| 2 | Consumer Discretionary | 14.02% |
| 3 | Healthcare | 12.06% |
| 4 | Communication Services | 9.1% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
951
iShares China Large-Cap ETF
FXI
$6.96B
| $8.45M | 0.01% |
+181,900
| New | +$8.45M |
|
|
EBIX
952
DELISTED
Ebix Inc
EBIX
| $8.45M | 0.01% |
222,413
+199,130
| +855% | +$7.56M |
|
953
Alnylam Pharmaceuticals
ALNY
$61.5B
| $8.38M | 0.01% |
64,501
-105,737
| -62% | -$13.7M |
|
954
Stratasys
SSYS
$838M
| $8.34M | 0.01% |
+402,381
| New | +$8.34M |
|
955
Advanced Energy
AEIS
$5.93B
| $8.3M | 0.01% |
85,626
+2,492
| +3% | +$242K |
|
956
Stifel
SF
$11.8B
| $8.28M | 0.01% |
164,129
+50,727
| +45% | +$2.56M |
|
957
Southwest Gas
SWX
$5.67B
| $8.28M | 0.01% |
136,296
+51,960
| +62% | +$3.16M |
|
958
TripAdvisor
TRIP
$2.06B
| $8.27M | 0.01% |
287,326
-306,763
| -52% | -$8.83M |
|
959
Enova International
ENVA
$2.88B
| $8.27M | 0.01% |
333,737
+270,686
| +429% | +$6.71M |
|
|
WRI
960
DELISTED
Weingarten Realty Investors
WRI
| $8.26M | 0.01% |
381,329
-140,432
| -27% | -$3.04M |
|
961
Patterson-UTI
PTEN
$2.14B
| $8.19M | 0.01% |
1,556,367
-121,678
| -7% | -$640K |
|
962
Visteon
VC
$3.42B
| $8.17M | 0.01% |
65,116
-46,942
| -42% | -$5.89M |
|
|
CRON
963
Cronos Group
CRON
$969M
| $8.17M | 0.01% |
1,176,705
+410,646
| +54% | +$2.85M |
|
|
BLUE
964
DELISTED
bluebird bio
BLUE
| $8.16M | 0.01% |
14,557
-8,937
| -38% | -$5.01M |
|
965
Vital Energy
VTLE
$647M
| $8.15M | 0.01% |
413,822
+257,234
| +164% | +$5.07M |
|
966
Alkermes
ALKS
$4.45B
| $8.12M | 0.01% |
407,096
-308,034
| -43% | -$6.14M |
|
967
Sherwin-Williams
SHW
$89.1B
| $8.12M | 0.01% |
33,135
+17,280
| +109% | +$4.23M |
|
968
Donnelley Financial Solutions
DFIN
$1.49B
| $8.1M | 0.01% |
477,264
-120,174
| -20% | -$2.04M |
|
|
IMGN
969
DELISTED
Immunogen Inc
IMGN
| $8.1M | 0.01% |
1,255,682
-385,734
| -24% | -$2.49M |
|
970
Agios Pharmaceuticals
AGIO
$2.12B
| $8.06M | 0.01% |
186,030
-149,640
| -45% | -$6.48M |
|
971
TrueCar
TRUE
$199M
| $8.03M | 0.01% |
1,912,288
-547,435
| -22% | -$2.3M |
|
|
PRSU
972
Pursuit Attractions and Hospitality, Inc.
PRSU
$1.02B
| $7.99M | 0.01% |
221,012
-68,531
| -24% | -$2.48M |
|
973
Nano X Imaging
NNOX
$254M
| $7.98M | 0.01% |
174,762
+74,039
| +74% | +$3.38M |
|
974
Repligen
RGEN
$6.72B
| $7.97M | 0.01% |
41,574
-77,007
| -65% | -$14.8M |
|
975
Manitowoc
MTW
$357M
| $7.94M | 0.01% |
596,547
+275,897
| +86% | +$3.67M |
|